AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Rhea-AI Summary
Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 47th Annual Global Healthcare Conference at 9:20 a.m. ET on Tuesday, June 9, 2026. Executives Peter Griffith and Murdo Gordon will speak, with a live webcast and replay available via Amgen's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – AMGN
In the Jun 5 session, AMGN gained 1.15%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 03 | EULAR data presentations | Positive | +3.0% | New Phase 3 and real-world data across rare autoimmune diseases. |
| May 29 | Jefferies conference | Neutral | -2.3% | Management presentation at major healthcare investor conference. |
| May 27 | Venture investment | Positive | +0.0% | Amgen Ventures participation in Ember LifeSciences Series A round. |
| May 19 | CFO transition | Neutral | -0.3% | Announcement of CFO retirement and planned successor transition. |
| May 07 | BofA conference | Neutral | +0.8% | Investor conference presentation featuring CFO and R&D leadership. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent AMGN headlines around conferences and external investments have generally seen modest, directionally aligned price reactions, with no consistent pattern of selling into such news.
Over the past month, AMGN has highlighted multiple investor and medical conference appearances and a strategic venture investment. On June 3, 2026, EULAR 2026 data presentations aligned with a +3.03% move. Prior presentations at Jefferies and Bank of America conferences saw moderate reactions, while an Ember LifeSciences investment and a CFO retirement produced only small price changes. Today’s Goldman Sachs conference appearance fits into this ongoing investor-relations and data-sharing cadence.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.
CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302791943.html
SOURCE Amgen